As we would expect increased glycolysis to be reflected in elevated frequencies of activated T cells in IBD patients, levels of the early activation marker CD69 and the late activation marker CD134 were determined in IBD patients as compared to non‐IBD patients. This evidence concerns the gene CD69 and inflammatory bowel disease.